^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Esophageal Cancer |
| Drug: | 5-fluorouracil (Thymidylate synthase inhibitor) + oxaliplatin (DNA synthesis inhibitor, DNA cross linking agent) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Esophageal and Esophagogastric Junction Cancers: Preferred regimens…Fluorouracil and oxaliplatin…
